drugset / Trial / NCT01537705

A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy

NCT01537705 ↗

Phase 2 Unknown 24 enrolled Targeted Medical Pharma
NaSingle-groupOpen-labelTreatment

Summary

A clinical outcomes study measuring reduction in pain and numbness experienced in four types of peripheral neuropathy patients during 60 day administration of the an amino acid formulation.

Timeline

Start
2012-03
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Neuron012703 Unknown — —